A serine loop in tissue factor mediates substrate selectivity by the tissue factor-factor VIIa complex

Area of Science:

• Biochemistry
• Molecular Biology
• Hemostasis

Background:

• The tissue factor-factor VIIa (TF-FVIIa) complex is central to initiating blood coagulation.
• TF-FVIIa activates two key substrates: factor IX (FIX) and factor X (FX).
• The mechanism underlying TF-FVIIa's substrate selectivity between FIX and FX is not fully understood.

Purpose of the Study:

• To investigate the role of a specific serine loop in tissue factor (TF) in mediating substrate selectivity.
• To determine how TF-FVIIa distinguishes between FIX and FX activation.
• To elucidate the interplay between the TF serine loop and the TF exosite in substrate recognition.

Main Methods:

• Generation of TF serine loop and exosite mutants.
• Enzyme activation assays measuring FIX and FX cleavage rates.
• Thrombin generation assays to assess overall clotting activity.

Main Results:

• Alterations in the serine loop length significantly impacted FX activation (up to 200-fold decrease) but minimally affected FIX activation.
• The TF serine loop was found to regulate the TF exosite during FX activation.
• The serine loop did not influence the exosite's role in FIX activation.

Conclusions:

• A TF serine loop plays a critical role in the selective activation of FX over FIX by the TF-FVIIa complex.
• This selectivity is achieved through the regulation of the TF exosite by the serine loop.
• These findings provide novel insights into the molecular mechanisms of TF-FVIIa-mediated substrate selection.